(Q84186549)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22613676%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

title

Immunosuppressive drugs on inducing Ag-specific CD4(+)CD25(+)Foxp3(+) Treg cells during immune response in vivo (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22613676%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22613676%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

author name string

Tingting Wu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22613676%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Lianjun Zhang

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22613676%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Kerui Xu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22613676%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Chenming Sun

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22613676%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Tong Lei

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22613676%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Jianxia Peng

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22613676%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Ruoyu Wang

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22613676%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

Yong Zhao

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22613676%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

publication date

14 May 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22613676%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

published in

Transplant Immunology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22613676%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22613676%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22613676%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

page(s)

30-38

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22613676%20AND%20SRC:MED&resulttype=core&format=json

Immunosuppressive strategies in transplantation

2 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2012.05.001

Foxp3 in control of the regulatory T cell lineage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2012.05.001

Challenges to achieving clinical transplantation tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2012.05.001

New insights into mechanisms of spontaneous liver transplant tolerance: the role of Foxp3-expressing CD25+CD4+ regulatory T cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2012.05.001

The different effects of cyclosporin A and rapamycin on regulatory CD4+CD25+ T cells: potential relationship with transplant tolerance induction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2012.05.001

Elevated T regulatory cells in long-term stable transplant tolerance in rhesus macaques induced by anti-CD3 immunotoxin and deoxyspergualin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2012.05.001

The effect of immunosuppressive drug rapamycin on regulatory CD4+CD25+Foxp3+T cells in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2012.05.001

Calcineurin inhibitors, but not rapamycin, reduce percentages of CD4+CD25+FOXP3+ regulatory T cells in renal transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2012.05.001

Rapamycin selectively expands CD4+CD25+FoxP3+ regulatory T cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2012.05.001

A potential side effect of cyclosporin A: inhibition of CD4(+)CD25(+) regulatory T cells in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2012.05.001

15-Deoxyspergualin and cyclophosphamide, but not mycophenolate mofetil, prolong survival and attenuate renal disease in a murine model of ANCA-associated crescentic nephritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2012.05.001

Mycophenolate mofetil combined with a cyclooxygenase-2 inhibitor ameliorates murine lupus nephritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2012.05.001

Additive effects of leflunomide and tacrolimus in prevention of islet xenograft rejection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2012.05.001

Induction of regulatory T cells by leflunomide in a murine model of contact allergen sensitivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2012.05.001

Homeostatic proliferation of naïve CD8+ T cells depends on CD62L/L-selectin-mediated homing to peripheral LN.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2012.05.001

The sphingosine 1-phosphate receptor agonist FTY720 potently inhibits regulatory T cell proliferation in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2012.05.001

Cyclophosphamide enhances the antitumor efficacy of adoptively transferred immune cells through the induction of cytokine expression, B-cell and T-cell homeostatic proliferation, and specific tumor infiltration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2012.05.001

Cyclophosphamide augments inflammation by reducing immunosuppression in a mouse model of allergic airway disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2012.05.001

Induction of Foxp3 demethylation increases regulatory CD4+CD25+ T cells and prevents the occurrence of diabetes in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2012.05.001

Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2012.05.001

The regulation of Foxp3 expression in regulatory CD4(+)CD25(+)T cells: multiple pathways on the road

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2012.05.001

Differential responses of human regulatory T cells (Treg) and effector T cells to rapamycin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2012.05.001

Selective survival of naturally occurring human CD4+CD25+Foxp3+ regulatory T cells cultured with rapamycin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2012.05.001

Daily subcutaneous injections of peptide induce CD4+ CD25+ T regulatory cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2012.05.001

Recurrent superantigen exposure in vivo leads to highly suppressive CD4+CD25+ and CD4+CD25- T cells with anergic and suppressive genetic signatures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2012.05.001

The role of positive costimulatory molecules in transplantation and tolerance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2012.05.001

CD4+CD25+ regulatory T cells in transplantation: progress, challenges and prospects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2012.05.001

Adaptive TGF-beta-dependent regulatory T cells control autoimmune diabetes and are a privileged target of anti-CD3 antibody treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2012.05.001

Compared to mycophenolate mofetil, rapamycin induces significant changes on growth factors and growth factor receptors in the early days post-kidney transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2012.05.001

Rapamycin induces transforming growth factor-beta production by lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2012.05.001

Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2012.05.001

Tolerance, not immunity, crucially depends on IL-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2012.05.001

Cutting edge: IL-2 is critically required for the in vitro activation of CD4+CD25+ T cell suppressor function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2012.05.001

IL-2 receptor alpha deficiency and features of primary biliary cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2012.05.001

Differential impact of mammalian target of rapamycin inhibition on CD4+CD25+Foxp3+ regulatory T cells compared with conventional CD4+ T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2012.05.001

Apoptosis of CD4(+)CD25(high) T cells in response to Sirolimus requires activation of T cell receptor and is modulated by IL-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2012.05.001

An oscillatory switch in mTOR kinase activity sets regulatory T cell responsiveness.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2012.05.001

Regulatory T cells require mammalian target of rapamycin signaling to maintain both homeostasis and alloantigen-driven proliferation in lymphocyte-replete mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2012.05.001

Impact of immunosuppressants on the therapeutic efficacy of in vitro-expanded CD4+CD25+Foxp3+ regulatory T cells in allotransplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2012.05.001

Mycophenolate mofetil modifies kidney tubular injury and Foxp3+ regulatory T cell trafficking during recovery from experimental ischemia-reperfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2012.05.001

Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2012.05.001

The role of cytochrome P450 in cytotoxic bioactivation: future therapeutic directions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2012.05.001

Immune-potentiating effects of the chemotherapeutic drug cyclophosphamide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2012.05.001

Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2012.05.001

Increase of CD4+ CD25+ regulatory T cells in the peripheral blood of patients with metastatic carcinoma: a Phase I clinical trial using cyclophosphamide and immunotherapy to eliminate CD4+ CD25+ T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2012.05.001

Selective depletion of CD4+CD25+Foxp3+ regulatory T cells by low-dose cyclophosphamide is explained by reduced intracellular ATP levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2012.05.001

Differential effect of calcineurin inhibitors, anti-CD25 antibodies and rapamycin on the induction of FOXP3 in human T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2012.05.001

Rapamycin, and not cyclosporin A, preserves the highly suppressive CD27+ subset of human CD4+CD25+ regulatory T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2012.05.001

The S1P(1)-mTOR axis directs the reciprocal differentiation of T(H)1 and T(reg) cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2012.05.001

T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2012.05.001

The AKT-mTOR axis regulates de novo differentiation of CD4+Foxp3+ cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIM.2012.05.001

10.1016/J.TRIM.2012.05.001

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22613676%20AND%20SRC:MED&resulttype=core&format=json

2 February 2020

1 reference